Abstract:Abstract Background Extracellular protein-protein interactions (PPIs) play a crucial role in cell-cell adhesion, communication, and signaling. The dysregulation of PPIs in cancer caused by differential protein expression can drive oncogenic factors. Traditional methods to study PPIs disfavor weak or transient interacting protein partners, leaving them undiscovered. Proximity labeling (PL) is an emerging tool in which a catalyst is attached to a protein of interest (POI) and creates reactive species that tag nearby endogenous proteins. Tagged proteins are subsequently isolated and identified as potential interacting partners with the POI. If PL could be activated at a more specific subcellular location, such as the site of a PPI, more detailed information could be unveiled concerning the interactome of cancer-relevant PPIs. Recent advances in PL involve the use of a synthetic catalyst that can be localized to a POI via an antibody or ligand and avoids the need for PL enzyme-POI fusion proteins to be constructed, allowing for analysis of primary tissue samples. Methods To create a PL catalyst with pseudo-allosteric regulation, we created a switchable DNA catalyst. The DNA catalyst is composed of synthetic photocatalyst and quencher moieties covalently linked to DNA oligomers such that when hybridized together the photocatalyst is quenched and inactive. The DNA scaffold affords conformational control that is utilized to change the distance between photocatalyst and quencher, thus regulating photocatalyst activity. Split triggers composed of DNA oligos that bind to catalyst-DNA and simultaneously disrupt quencher-DNA hybridization were used to create an AND logic gate where both split triggers need to be in proximity to activate the PL catalyst. The split triggers were localized to POIs via connection to aptamers, short pieces of synthetic DNA that bind targets. Using the c-Met homodimer as a model system, we first labeled c-Met expressing HEK293T cells with aptamer-split trigger DNA oligomers as well as the quenched photocatalyst. After the catalyst was activated at the site of the PPI, we performed proximity labeling using a biotin-phenol substrate in the presence of an oxidizing agent and 450 nm light. Fluorescent streptavidin was used to visualize sites of biotinylation and detected using fluorescence microscopy. Results We observed extracellular biotin signal only of c-Met transfected cells as evidenced by the expression of a co-transfection plasmid encoding a fluorescent nuclear protein. When one of the split triggers had the aptamer motif removed, meaning it couldn’t be localized to the cell surface, no labeling was observed which shows that both split probes must be localized to the cell surface to activate labeling. Additionally, controls including omission of light, photocatalyst, or biotin phenol showed no labeling. Using a free-floating version of the photocatalyst to label cells, we confirmed that lysates contained biotinylated proteins via western blot. Conclusion We localized two split triggers to interacting proteins to activate a PL catalyst and performed proximity labeling at the site of the PPI. This technique demonstrates non-genetic split proximity labeling to enable downstream analysis of cancer cell proteomes in an ultra-specific manner and expands the toolkit for spatiotemporally controlled proximity labeling.

Coupling proximity biotinylation with genomic targeting to characterize locus-specific changes in chromatin environments

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

A CRISPR-based approach for proteomic analysis of a single genomic locus

Proximity Utilizing Biotinylation of Nuclear Proteins in vivo

Programmable human histone phosphorylation and gene activation using a CRISPR/Cas9-based chromatin kinase

Tracking chromatin state changes using nanoscale photo-proximity labelling

Protocol to target a promoter region in human embryonic kidney cells using the CRISPR-dCas9 system for single-locus proteomics

PROBER Identifies Proteins Associated with Programmable Sequence-Specific DNA in Living Cells

Locus-specific chromatin proteomics using dCas-guided proximity labelling in Aspergillus nidulans.

In Situ Capture of Chromatin Interactions by Biotinylated Dcas9

B-291 Proximity Labeling at Sites of Protein-Protein Interactions Using a Switchable DNA Catalyst

Multiplexed Capture of Spatial Configuration and Temporal Dynamics of Locus-Specific 3D Chromatin by Biotinylated Dcas9

In situ chromatin interactomics using a chemical bait and trap approach

Coupling CRISPR Scanning with Targeted Chromatin Accessibility Profiling using a Double-Stranded DNA Deaminase

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Monitoring phosphorylation and acetylation of CRISPR-mediated HiBiT-tagged endogenous proteins

TurboID-mediated proximity labelling of cytoophidium proteome in Drosophila

Cysteine‐independent CRISPR‐associated protein labeling for presentation and co‐delivery of molecules toward genetic and epigenetic regulations

Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens

Photoproximity Labeling from Single Catalyst Sites Allows Calibration and Increased Resolution for Carbene Labeling of Protein Partners In Vitro and on Cells

Control of TurboID-dependent biotinylation intensity in proximity ligation screens